We are live on ! Find out more
BMRA icon

Biomerica

33 hedge funds and large institutions have $4.68M invested in Biomerica in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,700% more call options, than puts

Call options by funds: $76K | Put options by funds: $2K

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

37% more capital invested

Capital invested by funds: $3.43M → $4.68M (+$1.25M)

0.18% less ownership

Funds ownership: 2.97%2.79% (-0.18%)

6% less funds holding

Funds holding: 3533 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
33
Holders Change
-2
Holders Change %
-5.71%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
12
Reduced
8
Closed
6
Calls
$76K
Puts
$2K
Net Calls
+$74K
Net Calls Change
+$74K

BMRA Hedge Fund Activity: Q4 2023 in Review

33 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q4 2023, worth a combined $4.68M — up 37% from $3.43M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BMRA and 4 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 12 added.

The largest buyer was Susquehanna International Group, adding an estimated $61.1K. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $202K sold.

  • 33 institutional investors held Biomerica (BMRA) as of Q4 2023, down from 35 in Q3 2023.
  • Funds reported $4.68M of Biomerica stock for Q4 2023, up 37% quarter-over-quarter.
  • 4 funds opened new Biomerica positions in Q4 2023 and 6 closed out, a net change of -2 holders.
  • The largest Biomerica buyer in Q4 2023 was Susquehanna International Group, an estimated $61.1K added.
  • The largest Biomerica seller in Q4 2023 was Boothbay Fund Management, an estimated $202K sold.

Based on aggregated 13F filings for Q4 2023.